Skip to main content

Coherus BioSciences to Report Third Quarter 2022 Financial Results on November 8th, 2022

REDWOOD CITY, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2022 financial results will be released after market close on Tuesday, November 8th, 2022. Starting at 5:00 p.m. Eastern Time on November 8, 2022, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. The press release with the third quarter 2022 financial results and related materials will be available at https://investors.coherus.com prior to the start of the conference call.

A replay of the webcast will be available on http://investors.coherus.com following the conclusion of the live conference call.

Conference Call Information
When: Tuesday, November 8th, 2022, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and personal PIN to access the live call: https://register.vevent.com/register/BI79684ca1b45c46df988c8f9aac6f09af

Webcast: https://investors.coherus.com/upcoming-events

Please dial-in 15 minutes early to ensure a timely connection to the call.

Coherus Contact Information:
Marek Ciszewski, SVP Investor Relations
Coherus Biosciences, Inc.
IR@coherus.com



Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.05
+2.74 (1.18%)
AAPL  249.62
+1.97 (0.80%)
AMD  252.17
+2.37 (0.95%)
BAC  52.55
+0.48 (0.91%)
GOOG  331.38
+3.00 (0.91%)
META  637.43
+24.47 (3.99%)
MSFT  447.28
+3.17 (0.71%)
NVDA  185.23
+1.91 (1.04%)
ORCL  178.14
+4.26 (2.45%)
TSLA  436.29
+4.85 (1.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.